M Furutani

1.1k total citations
16 papers, 979 citations indexed

About

M Furutani is a scholar working on Surgery, Molecular Biology and Oncology. According to data from OpenAlex, M Furutani has authored 16 papers receiving a total of 979 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Surgery, 6 papers in Molecular Biology and 5 papers in Oncology. Recurrent topics in M Furutani's work include Angiogenesis and VEGF in Cancer (4 papers), Drug Transport and Resistance Mechanisms (3 papers) and Liver physiology and pathology (3 papers). M Furutani is often cited by papers focused on Angiogenesis and VEGF in Cancer (4 papers), Drug Transport and Resistance Mechanisms (3 papers) and Liver physiology and pathology (3 papers). M Furutani collaborates with scholars based in Japan and United States. M Furutani's co-authors include Shigeki Arii, M Imamura, S Ishigami, Masanori Niwano, T. HARADA, Masaki Mizumoto, M Mise, Hisashi Onodera, Akihiro Mori and Hidenori Nakayama and has published in prestigious journals such as Hepatology, Biochemical Journal and British Journal of Cancer.

In The Last Decade

M Furutani

16 papers receiving 961 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M Furutani Japan	11	593	378	354	236	115	16	979
Mary Matli United States	13	806 1.4×	424 1.1×	431 1.2×	155 0.7×	160 1.4×	20	1.3k
S Ishigami Japan	4	449 0.8×	307 0.8×	272 0.8×	214 0.9×	102 0.9×	6	739
Joanna W. Ho Hong Kong	15	638 1.1×	281 0.7×	283 0.8×	346 1.5×	60 0.5×	16	1.1k
Masaharu Furutani Japan	18	366 0.6×	244 0.6×	258 0.7×	286 1.2×	93 0.8×	26	892
L. Nakopoulou Greece	21	557 0.9×	278 0.7×	447 1.3×	57 0.2×	106 0.9×	53	1.1k
Lucia Fallavollita Canada	17	669 1.1×	421 1.1×	685 1.9×	114 0.5×	119 1.0×	23	1.5k
Arihiro Aihara Japan	19	513 0.9×	327 0.9×	408 1.2×	146 0.6×	87 0.8×	45	999
Miguel Murillo Spain	14	662 1.1×	151 0.4×	379 1.1×	160 0.7×	144 1.3×	16	1.1k
Carmen de Juan Spain	20	434 0.7×	237 0.6×	375 1.1×	137 0.6×	124 1.1×	50	1.0k
Renan Jin China	17	703 1.2×	463 1.2×	274 0.8×	258 1.1×	195 1.7×	34	1.2k

Countries citing papers authored by M Furutani

Since Specialization

Citations

This map shows the geographic impact of M Furutani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Furutani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Furutani more than expected).

Fields of papers citing papers by M Furutani

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M Furutani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Furutani. The network helps show where M Furutani may publish in the future.

Co-authorship network of co-authors of M Furutani

This figure shows the co-authorship network connecting the top 25 collaborators of M Furutani. A scholar is included among the top collaborators of M Furutani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M Furutani. M Furutani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Furutani, M, et al.. (2005). Elevation of serum thioredoxin levels in patients with nonalcoholic steatohepatitis. Hepatology Research. 33(2). 135–7. 24 indexed citations

Mori, Akira, Shigeki Arii, M Furutani, et al.. (2000). Soluble Flt-1 gene therapy for peritoneal metastases using HVJ-cationic liposomes. Gene Therapy. 7(12). 1027–1033. 53 indexed citations

Tanaka, Jun, et al.. (2000). Perioperative quantitative analysis of cytokeratin 20 mRNA in peripheral venous blood of patients with colorectal adenocarcinoma.. Oncology Reports. 7(2). 271–6. 10 indexed citations

Arii, Shigeki, M Furutani, Masaki Mizumoto, et al.. (2000). Mouse macrophage metalloelastase gene transfer into a murine melanoma suppresses primary tumor growth by halting angiogenesis.. PubMed. 6(5). 1647–54. 69 indexed citations

Arii, Shigeki, M Furutani, T. HARADA, et al.. (1998). Identification of Macrophage Metalloelastase in Hepatocellular Carcinoma:Correlation With Angiostatin Generation and its Clinical Significance. 99. 452. 5 indexed citations

Hayashi, Teruo, et al.. (1998). Neuroleptic‐induced Meige's syndrome following akathisia: Pharmacologic characteristics. Psychiatry and Clinical Neurosciences. 52(4). 445–448. 5 indexed citations

Ishigami, S, Shigeki Arii, M Furutani, et al.. (1998). Predictive value of vascular endothelial growth factor (VEGF) in metastasis and prognosis of human colorectal cancer. British Journal of Cancer. 78(10). 1379–1384. 294 indexed citations

Furutani, M, Shigeki Arii, Hiroaki Higashitsuji, et al.. (1996). Kan–1 (Bile Acid Coa:Amino Acid N –Acyltransferase) Messenger Rna As A Novel Predictive Indicator for Prognosis of Hepatocellular Carcinoma Patients After Partial Hepatectomy. Hepatology. 24(6). 1441–1445. 2 indexed citations

Furutani, M. (1996). Kan-1 (Bile acid CoA:Amino acid N-acyltransferase) messenger RNA as a novel predictive indicator for prognosis of hepatocellular carcinoma patients after partial hepatectomy. Hepatology. 24(6). 1441–1445. 10 indexed citations

10.

Mise, M, Shigeki Arii, M Furutani, et al.. (1996). Clinical significance of vascular endothelial growth factor and basic fibroblast growth factor gene expression in liver tumor. Hepatology. 23(3). 455–464. 270 indexed citations

11.

Arii, Shigeki, M Mise, T. HARADA, et al.. (1996). Overexpression of Matrix Metalloproteinase 9 Gene in Hepatocellular Carcinoma With Invasive Potential. Hepatology. 24(2). 316–322. 165 indexed citations

12.

Arii, Shigeki, Hiroaki Higashitsuji, M Furutani, et al.. (1996). Chemical Mediators Released by Primary–Cultured Human Hepatic Macrophages in Patients With and Without Cirrhosis: A Study in Tumor–Bearing Patients. Hepatology. 23(6). 1353–1358. 2 indexed citations

13.

Arii, Shigeki, M Furutani, M Mise, et al.. (1995). Suppression of the reperfusion injury of cold-preserved livers by Kupffer cell blockade.. PubMed. 27(1). 765–7. 2 indexed citations

14.

Furutani, M, Shigeki Arii, Hiroaki Higashitsuji, et al.. (1995). Reduced expression of kan-1 (encoding putative bile acid-CoA-amino acid N-acyltransferase) mRNA in livers of rats after partial hepatectomy and during sepsis. Biochemical Journal. 311(1). 203–208. 23 indexed citations

15.

Higashitsuji, Hiroaki, Shigeki Arii, M Furutani, et al.. (1995). Enhanced expression of multiple protein tyrosine phosphatases in the regenerating mouse liver: isolation of PTP-RL10, a novel cytoplasmic-type phosphatase with sequence homology to cytoskeletal protein 4.1.. PubMed. 10(2). 407–14. 26 indexed citations

16.

Furutani, M, Shigeki Arii, Y Adachi, et al.. (1994). Immunologic activation of hepatic macrophages in septic rats: a possible mechanism of sepsis-associated liver injury.. PubMed. 123(3). 430–6. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact